Phase 1/2 trials of human bone marrow–derived clonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis

Dermatology and Aesthetic
Facebook Whatsapp Copy Link
Dermatology and Aesthetic Dermatite